Peter Brossart

University Hospital Bonn — Germany

Immunology and Microbiology · Life Sciences

75h-index19.7kcitations547works2.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(151), Cancer Immunotherapy and Biomarkers(79), Immune Cell Function and Interaction(56), CAR-T cell therapy research(48), Chronic Myeloid Leukemia Treatments(45)

Publications543 total

NLRP3-induced systemic inflammation controls the development of JAK2V617F mutant myeloproliferative neoplasms
Nature Communications·2025· 1 citedOpen Access
Sepsis and organ failure are the major risks for allogeneic transplant patients in the post- or late- engraftment phase admitted to the ICU
Hematology·2025Open Access
On-treatment modified Glasgow Prognostic Score (mGPS) in hepatocellular carcinoma treated with atezolizumab and bevacizumab provides prognostic information
Frontiers in Immunology·2025Open Access
Dexamethasone induced Dectin-1 activation enhances NLRP3 inflammasome activation
Frontiers in Immunology·2025Open Access
Chronification of metastatic leiomyosarcoma in 9 lines of therapy by precision oncology: a case report and review of the literature
Frontiers in Oncology·2025Open Access
Sex-Disaggregated Analysis of Pneumonia in Patients with High-Risk Neutropenia
Oncology Research and Treatment·2025
500 | A COMPARATIVE ANALYSIS OF THE IMPACT OF NOVEL BTK INHIBITORS AND VENETOCLAX ON DENDRITIC CELL AND T CELL FUNCTION
Hematological Oncology·2025Open Access
Dose reduced induction therapy (A)-AIDA in patients with AML, being unfit for standard 7+3 chemotherapy and Literature Review of AML treatment in unfit/older AML patients
Acta Haematologica·2025
Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma
Journal for ImmunoTherapy of Cancer·2025· 4 citedOpen Access
Salvage autologous transplant in relapsed multiple myeloma: long-term follow-up of the phase 3 GMMG ReLApsE trial
Blood·2025· 12 citedOpen Access
Sequential Dosing of Next-Generation IMA203CD8 TCR-T-Cell Therapy Targeting PRAME in Combination with BRAF-/MEK-Inhibition in a Melanoma Patient with Progressive Disease - a Case Report
Blood·2024· 1 cited
The Immunomodulatory Effect of Different FLT3 Inhibitors on Dendritic Cells
Cancers·2024· 6 citedOpen Access
Bortezomib before and after high‐dose therapy in transplant‐eligible patients with newly diagnosed multiple myeloma: Long‐term overall survival after more than 10 years of follow‐up from the phase III HOVON‐65/GMMG‐HD4 trial
HemaSphere·2024· 2 citedOpen Access
Unleashing the potential of eHealth in outpatient cancer care for patients undergoing immunotherapy—a quantitative study considering patients’ needs and current healthcare challenges
Frontiers in Digital Health·2024· 3 citedOpen Access
Antibiotic Prophylaxis During Allogeneic Stem Cell transplantation—A Comprehensive Single Center Retrospective Analysis
Transplantation and Cellular Therapy·2024· 8 citedOpen Access
Anti-MDA5 autoantibodies predict clinical dynamics of dermatomyositis following SARS-CoV-2 mRNA vaccination: a retrospective statistical analysis of case reports
Rheumatology International·2024· 2 citedOpen Access
BIOLUMA: A phase II trial of nivolumab and ipilimumab in lung cancer—Results from the SCLC TMB<sup>high</sup> cohort.
Journal of Clinical Oncology·2024· 1 cited
CD24 is expressed in HNSCC and is correlated with a dampened immune response
Oral Oncology Reports·2024· 4 citedOpen Access
Transorbital ultrasound in the diagnosis of giant cell arteritis
Lara D. Veeken·2024· 12 citedOpen Access
Teledidactic Versus Hands-on Teaching of Abdominal, Thoracic, and Thyroid Ultrasound—The TELUS II Study
Journal of General Internal Medicine·2024· 8 citedOpen Access
page 1 of 28Next →

Frequent Co-authors

Lothar Kanz(13), Frank Grünebach(12), Wolfram Brugger(11), Annkristin Heine(8), Gernot Stuhler(6), Volker L. Reichardt(5), Arnold Ganser(5), Hartmut Döhner(5), Konstanze Döhner(5), Markus M. Weck(5), Alessio Nencioni(5), Stefan Wirths(4), Richard F. Schlenk(4), Lars Bullinger(4), Katharina S. Götze(4), Peter Paschka(4), Verena I. Gaidzik(4), Veronica Teleanu(4), Dominik Wolf‎(4), Martin Müller(4)